Cirrhosis Readmission Telehealth Project

Yale University10 enrolled

Overview

This is a 2 year research study to study if post discharge phone calls can help lengthen time to hospital readmissions for patients with encephalopathy.

The purpose of this randomized prospective pilot study is to decrease hospital readmissions for patients with hepatic encephalopathy. Patients who were admitted at YNHH with hepatic encephalopathy will be enrolled. Patients will then be randomized to one of two groups upon discharge. The control group will receive usual standard of care for hepatic encephalopathy (encephalopathy education, cirrhosis brochure, stool chart, and routine follow up with their primary care provider and hepatologist). The intervention group will receive usual standard of care as discussed above and phone calls for a 3-month period after their hospitalization.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Cirrhosis

Interventions

Phone callsBEHAVIORAL

Phone calls from medical staff assess confusion of the patient, and recommend immediate changes to dosage of lactulose.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age of at least 18 * Patients with known cirrhosis * Current hospitalization for overt hepatic encephalopathy as categorized by West Haven encephalopathy score of 2 or more * Current hospitalization found no precipitants triggering encephalopathy as determined by the primary team * Encephalopathy resolved at time of enrollment * Has a telephone * Able to obtain medications Exclusion Criteria: * Altered mental status unrelated to cirrhosis * Acute liver failure * Expectation of liver transplant within 1 month after enrollment * Chronic kidney disease with Cr \> 2 mg/dL * Respiratory insufficiency:moderate to sever COPD on pulmonary function test * Electrolyte imbalances not corrected at enrollment * Sodium less than 125 mmol/L * Calcium greater than 10mg/dL * Potassium \< 2.5mmol/L * Unable to give legal consent * Deafness * Infection, spontaneous bacterial peritonitis, gastrointestinal bleeding

Locations (1)

Yale New Haven Hospital

New Haven, Connecticut, United States

Outcomes

Primary Outcomes

Hospital Readmission

Time to hospital readmission after discharge during the 3 month study period for hepatic encephalopathy

Time frame: up to 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.